Weight loss and engagement: January 2026 analysis of 14,203 Noom GLP-1 Rx Program members who started a GLP-1 Rx plan between December 2024 and February 2025 and logged weight during a measurement week (4, 8, 16, 40 weeks)
Many lawsuits involve patients who suffered persistent and long-term complications , such as: permanent gastroparesis chronic pancreatitis long-term kidney impairment gallbladder removal irreversible GI motility disorders If long-term side effects developed after using a GLP-1 drug, you may qualify
A fresh analysis of the clinical and financial implications of comprehensive coverage in Medicare of GLP-1s for all current FDA indications (type 2 diabetes, obesity, heart disease and metabolic-associated steatohepatitis) offers some hope for long-term cost savings
Should be paired with lifestyle changes
Originally approved for medical use in the U.S